Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer.

J Ovarian Res · 2019 · PMC6935502 · PMID 31884974

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

Additionally, p < 0.05, p < 0.01 , and p < 0.001 were considered significant *, very significant ** and extremely significant ***, respectively.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.